CCXI Historical Earnings image   This CCXI historical earnings page last updated 11/8/2022
CCXI Historical Revenue
PeriodHistorical Earnings DateGAAP
Q2 20228/9/20220.01B
Q1 20225/5/20220.01B
Q4 20213/1/20220.00B
Q3 202111/9/20210.02B
Q2 20218/9/20210.00B
Q1 20214/29/20210.01B
Q4 20203/1/20210.00B
Q3 202011/9/20200.01B
Q2 20208/10/20200.05B
Q1 20205/11/20200.01B
Q4 20193/10/20200.01B
Q3 201911/4/20190.01B
Q2 20198/5/20190.01B
Q1 20195/6/20190.01B
Q4 20183/11/20199.33M
Q3 201811/8/20188.97M
Q2 20188/9/201815.02M
Q1 20185/9/20189.55M
Q4 20173/9/201856.30M
Q3 201711/7/20179.03M
Q2 20178/8/20178.94M
Q1 20175/10/20178.23M
Q4 20163/14/20174.89M
Q3 201611/7/20164.25M
Q2 20168/8/20162.79M
Q1 20165/10/2016NA
Q4 20153/14/2016NA
Q3 201511/9/2015NA
Q2 20158/6/2015NA
Q1 20155/6/2015NA
Q4 20143/12/2015NA
Q3 201411/5/2014NA
Q2 20148/5/2014NA
Q1 20145/8/2014NA
Q4 20133/13/2014730000
Q3 201311/7/20131.52M
Q2 20138/12/20131.89M
Q1 20135/13/20131.93M
Q4 20123/13/20132.10M
CCXI Historical Earnings EPS
PeriodHistorical Earnings DateGAAP
Q2 20228/9/2022-0.440
Q1 20225/5/2022-0.550
Q4 20213/1/2022-0.580
Q3 202111/9/2021-0.320
Q2 20218/9/2021-0.560
Q1 20214/29/2021-0.430
Q4 20203/1/2021-0.430
Q3 202011/9/2020-0.350
Q2 20208/10/20200.290
Q1 20205/11/2020-0.350
Q4 20193/10/2020-0.260
Q3 201911/4/2019-0.220
Q2 20198/5/2019-0.260
Q1 20195/6/2019-0.230
Q4 20183/11/2019-0.21
Q3 201811/8/2018-0.22
Q2 20188/9/2018-0.14
Q1 20185/9/2018-0.19
Q4 20173/9/20180.8
Q3 201711/7/2017-0.13
Q2 20178/8/2017-0.19
Q1 20175/10/2017-0.12
Q4 20163/14/2017-0.16
Q3 201611/7/2016-0.15
Q2 20168/8/2016-0.22
Q1 20165/10/2016-0.34
Q4 20153/14/2016-0.26
Q3 201511/9/2015-0.26
Q2 20158/6/2015-0.28
Q1 20155/6/2015-0.28
Q4 20143/12/2015-0.28
Q3 201411/5/2014-0.25
Q2 20148/5/2014-0.28
Q1 20145/8/2014-0.27
Q4 20133/13/2014-0.23
Q3 201311/7/2013-0.22
Q2 20138/12/2013-0.23
Q1 20135/13/2013-0.28
Q4 20123/13/2013-0.28
Quotes delayed 20 minutes

Email EnvelopeFree CCXI Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
ChemoCentryx (CCXI) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

CDAK Historical Earnings
CDMO Historical Earnings
CDNA Historical Earnings
CDRE Historical Earnings
CDTX Historical Earnings
CDXC Historical Earnings
CELC Historical Earnings
CEMI Historical Earnings
CERC Historical Earnings
CERE Historical Earnings
What was the record high CCXI historical earnings result?
In terms of earnings or revenue, what is the best CCXI historical earnings result that ChemoCentryx has ever posted, and when?

✔️Accepted answer: Within our data set, the highest CCXI historical earnings result was set in Q4 2017, when ChemoCentryx posted results of 0.8/share. The most successful revenue quarter within our data set was Q4 2017 when ChemoCentryx reported revenue of 56.30M.

What was the lowest ChemoCentryx historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest CCXI has reported, and when?

✔️Accepted answer: Within our data set, the lowest CCXI historical earnings result was set in Q4 2021, when ChemoCentryx posted results of -0.580/share. The smallest revenue quarter within our data set was Q1 2016 when ChemoCentryx reported revenue of NA.

On this page we presented the CCXI historical earnings date information for ChemoCentryx. Reviewing that CCXI Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q4 2017, when CCXI posted gaap of 0.8/share. Meanwhile the lowest CCXI historical earnings result was in Q4 2021, when CCXI posted gaap of -0.580/share. Moving to ChemoCentryxs historical revenue numbers, the largest revenue quarter in our data set was seen in Q4 2017 when CCXI reported 56.30M in revenue, while the smallest revenue quarter was Q1 2016 when CCXI reported NA in revenue.

For self directed investors doing their due diligence on CCXI or any other given stock, their research can benefit from looking into all of the ChemoCentryx historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you HistoricalEarnings.com to make it more convenient for investors to look into ChemoCentryx historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for CCXI. Thanks for visiting, and the next time you need to research CCXI historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.

Recommended: CYAD market cap history, Institutional Holders of YCBD, Top Ten Hedge Funds Holding HLG.

 

CCXI Historical Earnings | www.HistoricalEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.